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Homologous recombination (HR) is an important pathway for the accurate repair of potentially cytotoxic or mutagenic double strand breaks (DSBs), as well as double strand ends that arise due to replication fork breakdown. Thus, measuring HR events can provide information on conditions that induce DSB formation and replicative stress. To study HR events in vivo, we previously developed Fluorescent Yellow Direct Repeat (FYDR) mice in which a recombination event at an integrated transgene yields a fluorescent signal. Recently, we published an application of these mice demonstrating that fluorescent recombinant cells can be directly detected within intact pancreatic tissue. Here, we show that in situ imaging is a more sensitive method for detecting exposure-induced recombinant cells, yielding statistical significance with smaller cohorts. In addition, we show inter-mouse and gender-dependent variation in transgene expression, examine its impact on data interpretation, and discuss solutions to overcoming the effects of such variation. Finally, we also present data on enhanced yellow fluorescent protein (EYFP) expression, showing that several tissues, in addition to the pancreas, may be amenable for in situ detection of recombinant cells in the FYDR mice. The FYDR mice provide a unique tool for identifying genetic conditions and environmental exposures that induce genotoxic stress in a variety of tissues.
HOMOlOgOus RECOMBinAtiOn MODulAtEs CytOtOxiCity AnD gEnOMiC intEgRity
Mitotic homologous recombination (HR) is critical for the repair of genome destabilizing DNA damage, including double strand breaks (DSBs) and interstrand cross-links. These DNA lesions can be caused by environmental exposures, such as radiation or chemotherapy, and by endogenous cellular metabolites, such as reactive oxygen species. [1] [2] [3] [4] In addition, DSBs can occur as the result of DNA processing. For example, replication fork encounter with a DNA lesion or a single strand gap can cause replication fork breakdown, creating a double strand end. [5] [6] [7] [8] [9] HR is the only DNA repair pathway that can accurately repair replication fork associated double strand ends. 1, 2 With its critical role in the repair of replication-dependent and -independent DSBs, it is not surprising that mitotic HR is critical to human health. [10] [11] [12] [13] [14] In addition to HR, cells use another DNA repair pathway, nonhomologous end-joining (NHEJ), to recognize and repair DSBs. In contrast to HR which uses homologous sequences as templates for repair, NHEJ directly rejoins DSBs, regardless of sequence. 15, 16 In order to maintain genomic stability, cells maintain an appropriate balance between NHEJ and HR in the repair of DSBs. NHEJ is the preferred pathway during G 0 /G 1 phases of the cell cycle, whereas HR is critical during late S/G 2 . 17 Specifically, HR repairs broken replication forks that arise during S phase by reinserting broken ends into their respective sister chromatids. If the double strand ends were instead acted upon by NHEJ, the mis-joining of broken ends from independent replication forks at two different loci will inevitably lead to large scale sequence rearrangements that may be tumorigenic or cytotoxic. On the other hand, since a significant portion of the human genome is composed of repetitive elements, the repair of DSBs during G 0 /G 1 phases by HR could lead to exchanges between misaligned sequences that promote tumorigenic aberrations. 18 Thus, many inherited mutations in genes that modulate HR, whether up or down, are associated with an increased risk of cancer, 13, 14, 19 and defects in HR proteins are also often seen in sporadic cancers. [20] [21] [22] [23] www.landesbioscience.com Cell Cycle
Ironically, although DNA damage that inhibits replication can induce tumor-promoting sequence rearrangements, many agents used to treat cancer are in fact DNA damaging-agents that inhibit replication fork progression. Thus many chemotherapeutic agents are highly recombinogenic. [24] [25] [26] [27] [28] [29] Interestingly, elevated levels of HR proteins within tumor cells are associated with an increased resistance to many cancer chemotherapeutics [30] [31] [32] [33] [34] [35] and a poor prognosis for cancer survival. 36 In contrast, cancer cells deficient in HR (e.g., breast tumors with BRCA2 mutations 37, 38 ) are rendered sensitive to chemotherapeutic agents that induce replication fork breakdown. [39] [40] [41] [42] Therefore, knowledge about HR capacity is relevant both to one's risk of developing cancer 13, 14, 19 and to the response of a tumor to chemotherapy. [39] [40] [41] [42] [43] Although HR is an important pathway for overcoming the potential lethality and mutagenicity of replicative stress, studying HR has been difficult since many key HR proteins are either essential for viability [44] [45] [46] [47] [48] [49] or possibly sufficiently redundant that their absence does not fully reveal the role of this pathway in vivo. An alternative approach for studying HR is to measure DNA sequence rearrangements that result from HR events. Toward this end, we have developed Fluorescent Yellow Direct Repeat (FYDR) mice that enable the detection of HR events in vivo. 50 FYDR mice carry a direct repeat recombination substrate that contains two differently mutated copies of the coding sequence for enhanced yellow fluorescent protein (EYFP). An HR event can restore full length EYFP coding sequence, thus yielding a fluorescent cell (Fig. 1A) . One exciting advantage of using fluorescence as a marker for sequence changes is that cells harboring recombined DNA can potentially be detected within intact tissues.
ADvAntAgEs Of in situ DEtECtiOn
Recently, we have shown that fluorescent recombinant cells are directly detectable within pancreatic tissue. 51 Examination of aged mice by in situ imaging revealed a dramatic increase in not only the number but also the size of recombinant cell clusters (Fig. 1B) , indicating that both de novo events as well as clonal expansion contribute to the overall increase in the frequency of recombinant cells with age. The advantage of being able to detect the accumulation of de novo recombination events is that it enables the study of the cumulative effects of long term exposures on recombination. In addition, the ability to detect clonal expansion enables the identification of clonal cell populations in normal tissues. 52 Both the formation of new genetic changes and clonal expansion of cells with preexisting genetic changes contribute to cancer development. Therefore, being able to study conditions that induce new genetic changes as well as stimulate clonal outgrowth will likely yield interesting insights into the earliest steps of cancer formation.
Although the FYDR mice have been used to study the accumulation of environmentally induced recombinant cells in adult mice, 51 one limitation to the sensitivity of this assay is the variation in the frequency of spontaneous recombinant cells among mice. When the tissue is disaggregated and subsequently analyzed by flow cytometry, large recombinant cell clusters can lead to a high frequency of fluorescent recombinant cells, which could mask the induction of de novo exposure-induced recombinant cells. Therefore, the detection of discrete recombinant cell clusters by in situ imaging may be a more sensitive method for detecting de novo recombination events. We tested this hypothesis by comparing our ability to detect HR events after treatment with the DNA cross-linking agent mitomycin-C (MMC). Analysis by both in situ imaging and flow cytometry show an induction in recombinant cells in vivo. However, with ~24 mice per cohort, the induction was statistically significant only when foci were analyzed in situ ( Fig. 2A) . Statistical significance by flow cytometry was observed when approximately twice as many (~47) mice per cohort were analyzed (Fig. 2B ). These data show that because independent mutation events can be distinguished, in situ imaging provides a more sensitive method for determining environmentally induced mutations in adult tissues. Interestingly, many previously published mutation studies have been done by analyzing DNA from disaggregated tissue (e.g., Aprt, Tk, Big Blue, Muta Mouse, GptD), [53] [54] [55] an approach that limits information about the clonal relationship among mutant cells. The observation that in situ analysis is more sensitive than tissue disaggregation for detecting environmentally induced mutations raises the possibility that previous studies of disaggregated tissues may underestimate the impact of some environmental exposures. It is noteworthy that the techniques described here are not limited to HR and could potentially be applied to studies of other types of mutations.
COntROlling fOR vARiAtiOn in tRAnsgEnE ExPREssiOn lEvEls
In the course of studying MMC-induced recombination, we noticed an apparent difference in foci frequencies amongst males and females. Indeed, closer examination of recombinant foci in pancreata of FYDR mice reveals a statistically significant difference Images were collected at 1x (bar, 1 cm) using an EYFP filter (510-560 nm). The edge of the pancreatic tissue is outlined. This figure was adapted from Wiktor-Brown, et al. 51 in the number of recombinant foci between males and females (Fig. 3A) , even without exposure to exogenous DNA damaging agents. Although this difference in recombinant foci may be the result of differences in HR, it is also possible that this difference results from differences in the ability to detect fluorescent cells (e.g., differences in expression levels of EYFP). To explore the possibility that the higher number of recombinant foci in female pancreata may be due to higher levels of FYDR transgene expression, we exploited positive control FYDR-Recombined (FYDR-Rec) mice. FYDR-Rec mice arose spontaneously from an HR event in a FYDR parental gamete. Thus, all cells in FYDR-Rec mice carry the full-length EYFP coding sequence under the identical promoter and locus as the FYDR mice and have the potential to express EYFP. Therefore, the FYDR-Rec mice are the perfect positive control for FYDR transgene expression, and expression of the FYDR transgene can be analyzed simply by looking at expression of EYFP. We have measured the percentage of fluorescent cells from over 50 disaggregated positive control FYDR-Rec pancreata (Fig. 3B) . It is noteworthy that regardless of sex, pancreatic cells show a range of EYFP expression levels. However, the average percentage of cells expressing EYFP was statistically significantly higher in female mice. Therefore, the male-female difference in recombinant foci is at least partially due to differences in expression.
In addition to gender, exposures may also affect expression of the FYDR transgene. Thus, in addition to its effect on recombination, the effect of any condition on transgene expression should be determined concurrently in a cohort of FYDR-Rec mice. For example, to determine the effect of MMC treatment on FYDR transgene expression, we included mock-and MMC-treated FYDR-Rec cohorts in our study. Analysis of disaggregated FYDR-Rec pancreata showed that MMC treatment did not lead to any statistically significant change in the percentage of fluorescent cells (Fig. 3C) . These studies indicate that the increase in recombinant cells after MMC treatment in FYDR mice is indeed due to HR and not to an increase in expression of the FYDR transgene.
In the FYDR mice, expression of EYFP is controlled by the cytomegalovirus enhancer/chicken beta actin (CAG) promoter. Although this promoter has previously been shown to be ubiquitously expressed in all cell and tissue types, 56 this is not the case in our particular model. Histological analysis shows significant variation in expression levels even among the same cell type within a tissue. The variability in expression may be the result of the locus of integration and the number of integrated transgene copies (note that in these mice, a single copy of EYFP is expressed 50 ). Such expression variability is unlikely to be unique to this particular mouse model. Transgene expression variability within a single tissue type can have a tremendous impact on experimental design and data interpretation, resulting in the need to explore and control for inter-mouse variation in transgene expression. In our system, when comparing HR among different genetic conditions or environmental exposures, inter-mouse variation in transgene expression can be overcome by using appropriate FYDR cohort sizes and by using the positive control FYDR-Rec mice to determine the effect of a condition on transgene expression. Thus, the FYDR and FYDR-Rec mice together provide a unique system for determining the effect of any genetic condition or environmental exposure on HR.
futuRE APPliCAtiOns: stuDiEs Of HOMOlOgOus RECOMBinAtiOn in MultiPlE tissuEs
In our studies, we have focused on analyzing recombination in the pancreas, cutaneous tissue, and cultured primary ear fibroblasts. 50, 51, 57 In addition to the pancreas and skin, recombination in other tissues of the FYDR mouse can potentially be studied. However, one limitation of using fluorescence as a measure of recombination is that EYFP is not expressed equally in all cell types. In order to detect rare recombinant cells (~1-5/10 6 ), both a high signal to noise ratio and a large number of analyzable cells is required. To learn more about which tissue types are amenable for analysis, we examined the fluorescence signal to noise ratio in a variety of tissues from FYDR-Rec and negative control C57Bl/6 mice. These studies revealed that EYFP is detectable in multiple tissue types, but that the percentage of cells expressing EYFP and the brightness of EYFP expression are highly variable within each tissue (Fig. 4) and among individual mice (data not shown). In the pancreas (Fig. 4A) , EYFP expressing cells are generally extremely bright. Similar to the pancreas, expression of EYFP in skeletal muscle is uniform and comparable in brightness (data not shown). In contrast, EYFP expression is seen sporadically in renal tubular epithelial cells (Fig.  4B) , in biliary epithelial cells and in hepatocytes within the liver (data not shown), and in alveoli and bronchiolar epithelial cells within the lung (Fig. 4C) . Within these tissues, however, expression is generally dimmer than in the pancreas. Within the brain, EYFP expression is dim and limited to cells consistent with Purkinje cells (data not shown), although more experiments are needed to determine cell type. Lastly, in addition to tissue sections, flow cytometry analysis of cells from blood and bone marrow show that certain cell types within these tissues also express EYFP (data not shown). Since the ability to study recombination in certain tissues of FYDR mice depends upon the brightness of fluorescence, the fraction of cells expressing the FYDR transgene, and the total number of cells that can be analyzed from a given tissue, it may be more difficult to detect rare recombinant cells in tissues where EYFP expression is either dim or sporadic. However, given the sensitivity of epifluorescence for being able to detect as few as one recombinant cell within an entire pancreas (~3 x 10 7 cells 58 ) these preliminary studies suggest that with appropriate imaging techniques it may be possible to use the FYDR mice to study HR in a variety of tissues.
COnCluDing REMARKs
Using fluorescent proteins to mark cells that have undergone an HR event makes it possible to detect rare recombinant cells that arise in vivo and to learn about the underlying cell types that have undergone a recombination event. Furthermore, in situ detection enables differentiation between de novo and clonally expanded recombinant cells. By combining both in situ imaging and flow cytometry of disaggregated tissue, the effects of environmental exposures on both new mutation formation and clonal expansion can be revealed. One application of these approaches is to use the FYDR mice to study the recombinogenic effects of chemotherapeutic regimens, yielding valuable information about tissue specificity as well as potential long term effects of such exposures. Given that HR is a critical process for maintaining genomic integrity and for preventing DNA damageinduced cell death, in situ detection of fluorescent recombinant cells provides a sensitive approach for studying the potential genotoxic effects of pharmaceuticals and environmental exposures. 
